Avivagen Inc V.VIV.H

Alternate Symbol(s): VIVXF

Healthcare

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

TSXV:VIV.H - Post by User

Avivagen Inc > from Oct

<< Previous

Bullboard Posts

Next >>

Comment by StoneMan45on Nov 13, 2021 8:21am

103 Views

Post# 34122784

RE:from Oct

Conclusion The landmark deal announced with AB Vista could be a “game changer” for the company as Avivagen now has a global partner that gives immediate credibility to the OxC-beta technology. We believe management made the right move by limiting the deal with AB Vista to only a select few jurisdictions instead of going for a global deal. Once sales begin to ramp up, we believe it will be just a matter of time before interest in acquiring the company outright begins to increase, and by that time we are confident that the share price will more accurately reflect the company’s true value. Our valuation remains at $3.50.

<< Previous

Bullboard Posts

Next >>

Canadians having more difficulty saving for retirement, study finds